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 Mutations of SLC26A4 are associated with incomplete partition type II (IP-II) and isolated 
enlargement of the vestibular aqueduct (EVA). We experienced a congenitally deaf patient with a 
rare p.T410M homozygous mutation of SLC26A4. The patient had unusual inner ear malformations 
on both sides, in which the vestibules and vestibular aqueducts were identical to those in IP-II, but 
the cochleae lacked a bony modiolus and resembled those in incomplete partition type I. These 
results suggest that homozygous mutations in SLC26A4 are always associated with EVA, but that the 
severity of cochlear malformation may vary depending on the type of SLC26A4 mutation. 
 
Keywords:  SLC26A4, homozygous mutation, hearing loss, inner ear malformation, incomplete 
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 Severe or profound hearing loss occurs in approximately 1-2 of 1000 newborn children 
and genetic causes account for more than half of cases of congenital deafness [1, 2]. Mutations of the 
SLC26A4 gene, which encodes Pendrin, a member of the solute carrier family, are the second leading 
cause of autosomal recessive hearing loss and are strongly associated with inner ear malformation, 
including isolated enlargement of the vestibular aqueduct (EVA) and incomplete partition type II 
(IP-II), which is defined by a cochlea with confluence of the middle and apical turns, a minimally 
dilated vestibule, and EVA [3, 4]. Mutations of SLC26A4 result in non-syndromic or syndromic 
hereditary hearing loss [5, 6]. SLC26A4 was originally identified as the causative gene of Pendred 
syndrome, an autosomal recessive hereditary disease characterized by congenital hearing loss and 
early adult-onset thyroid goiter [7]. Subsequently, mutations of SLC26A4 have also been found in 
patients with familial non-syndromic sensorineural hearing loss with EVA [5].  









 exchanger across the plasma membrane in vitro [9-11]. Pendrin is 








 exchange in the inner ear [12]. 
To date, more than 170 mutations of SLC26A4, including missense, nonsense, frameshift, and splice 
site mutations, have been identified and these mutations are located throughout the coding region of 


































































genetic study in the Japanese population showed that the p.H723R mutation accounted for more than 
50% of identified SLC26A4 mutations, while the frequency of p.T410M is less than 10% and 
relatively rare, but is found in Asian, European and American populations [14-18]. Compound 
heterozygotes of p.T410M and another mutation, as well as the mono-allelic p.T410M mutation in 
SLC26A4 have been associated with isolated EVA or IP-II [19, 20]. However, only a few p.T410M 
homozygous patients have been described and the clinical features and radiographic findings in these 
cases have not been widely investigated [17, 21]. Here, we present the case of a congenitally deaf 
patient who was homozygous for p.T410M SLC26A4 and had an unusual inner ear malformation 
that was partly similar to IP-II, the typical malformation associated with SLC26A4 mutations, but 
clearly differed from IP-II because of cystic cochleae lacking a bony modiolus. 
  
2. Case report 
 The patient was an otherwise healthy 1-year-old boy who was referred to our hospital 
because of failure to pass newborn hearing screening. He had no family history of hearing loss and 
no history of prenatal or perinatal problems. He started to use bilateral hearing aids at 5 months old, 
but did not respond to surrounding sounds after 6 months of use of the hearing aids. An otoscopic 
examination revealed no abnormality in his tympanic membranes and ABR testing exhibited no 


































































patient showed neither developmental delay nor associated psychophysiological abnormalities, 
except for delayed speech development due to the profound sensorineural hearing loss. The Invader 
assay for screening of 47 mutations of 13 known deafness genes that are common in the Japanese 
population [22] identified a p.T410M homozygous mutation in the SLC26A4 gene. 
 CT images revealed a bilaterally symmetrical inner ear malformation with (1) a cystic 
cochlea without a bony modiolus, (2) a dilated vestibule, and (3) EVA (Fig. 1A-D), indicating 
characteristic features of IP-I (Fig. 1E, F) and IP-II (Fig. 1G, H). The cystic cochleae without a bony 
modiolus resembled those in IP-I, while the dilated vestibule and EVA were similar to those in 
typical IP-II found in patients with homozygous mutations of p.H723R, the most common mutation 
of SLC26A4 in Japan [14]. To confirm this finding, we measured the size of each part of the 
malformed inner ears (Table 1). The length of the basal portion and the height of the cochleae were 
8.81 mm and 4.93 mm, respectively, on the right side, and 9.10 mm and 5.51 mm, respectively, on 
the left side, which are similar to the width of 8.59 ± 0.41 mm and height of 5.31 ± 0.41 mm for 
normal cochleae [23]. The normal external dimensions of the cochleae and complete absence of the 
bony modiolus indicated cochleae similar to those observed in IP -I [4]. The widths of the vestibule 
were 4.03 mm and 4.18 mm on the right and left sides, respectively, which were shorter than the 
typical length of 5.74 ± 0.68 mm in IP-I, but similar to the length of 4.26 ± 0.38 in IP-II [23]. The 


































































right and left sides, respectively, which were larger than the criteria of 1.5 mm for EVA [4]. These 
findings showed that, unlike the cochleae, the vestibule and vestibular aqueduct on each side were 
typical of those found in IP-II. CT images also revealed a bony defect between the fundus of the IAC 
on both sides (Fig. 1 A, C). 
 T2-weighted MRI revealed that soft tissue separated the fundus of the IAC from the 
malformed cochlea on the right side, but that the IAC communicated with the cystic cochlea on the 
left side (Fig. 2A, B). A modiolus-like structure with low intensity on T2-weighted images was 
observed at the center of the right malformed cochlea, suggesting that neural tissue was present in 
the center of the cochlea, despite the lack of a bony modiolus, while the left side showed a complete 
empty cochlea. Interestingly, MRI showed that the endolymphatic sac was not enlarged, even though 
the vestibular aqueduct was significantly enlarged (Fig. 2A, B). In IP-II and isolated EVA, an EVA is 
always associated with an abnormally large endolymphatic sac, which is a clear contrast to the 
observations in the present case (Fig. 2C).  
 The patient underwent sequential bilateral cochlear implantation: the first implantation on 
the right side at 14 months old and the second on the left side at 6 years old. A perimodiolar hugging 
electrode array with half-banded electrodes and a straight electrode array with full banded electrodes 
(Nucleus CI24RECS and Nucleus CI24REST, respectively; Cochlear Ltd., Sydney, Australia) were 


































































gusher occurred during the left side implantation, but not on the right side, as predicted by the MRI 
findings showing a lack of the lateral end of the IAC on the left side, as described above. The CSF 
gusher on the left side was easily controlled by plugging of soft tissue at the cochleostomy. The 
patient understood conversation without lip-reading with a familiar talker at 14 months after the first 
implantation and scored 90% on a Japanese infant word discrimination test. No delay in language 
development was observed before the second implantation on the left side performed at 6 years old. 
     
3. Discussion 
 The patient in this case report had p.T410M homozygous mutation in the SLC26A4 gene 
and showed bilateral symmetric inner ear malformation on CT imaging, with a cystic cochlea, a 
dilated vestibule, and EVA. With regard to each part of the bony labyrinth, the cystic cochlea without 
a bony modiolus was similar to that observed in IP-I, while the dilated vestibule and EVA were 
identical to those in IP-II. MRI showed that a basement membrane-like structure divided the 
membrane labyrinth into the scala tympani and scala vestibuli in the left malformed cochlea, 
suggesting that this cochlea was more differentiated than the completely empty cochlea observed in 
typical IP-I [4, 23]. MRI also showed that each side of the endolymphatic sac was not dilated, even 
though the vestibular aqueduct was as wide as those in isolated EVA and IP-II. 


































































characteristic features of both IP-I and IP-II and could be classified between IP-I and IP-II using the 
classification of inner ear malformations published in 2010 by Sennaroglu [4]. In this classification, 
EVA is observed in cochlear hypoplasia type II other than IP-II and isolated EVA. Cochlear 
hypoplasia type II is defined by (1) smaller dimensions of the cochlea with no modiolus and 
interscalar septa, (2) normal external architecture of the cochlea, (3) a minimally dilated vestibule, 
and (4) EVA [4]. The malformed inner ears in our case resembled cochlear hypoplasia type II, but 
did not meet the first criterion. The outer diameters of the cochleae were as large as those of normal 
cochleae and based on this finding we concluded that the malformed inner ears were not cochlear 
hypoplasia type II, but rather were located between IP-I and IP-II. 
 To our knowledge, this is the first reported case with bi-allelic SLC26A4 mutations and a 
cystic cochlea without a bony modiolus. Many studies have shown that homozygous or compound 
heterozygous mutations in SLC26A4 are associated with LVAS and IP-II [24], in which the cochlea 
is normal and mildly malformed, respectively, and the bony modiolus is always present. The results 
in our patient with a p.T410M homozygous SLC26A4 mutation suggest that EVA is a universal 
phenotype among SLC26A4 mutations [25], while the severity of cochlear malformations may vary 
widely between patients with bi-allelic SLC26A4 mutations. The p.T410M mutation in SLC26A4 has 
been found in Asian, European, and American populations, but the frequency is not high among 


































































26]. To date, 8 patients with SLC26A4 p.T410M homozygous mutations from 5 families have been 
reported in the English literature [15-18, 26]. Among these, only a report from Spain described no 
inner ear malformation except for EVA in 4 patients of the same family, but CT images were not 
shown [17]. The other reports did not mention abnormalities other than EVA. 
 For genetic testing in the present case, we used the Invader assay, which is optimized for 
screening for 47 common mutations of 13 causative genes in the Japanese deafness population [14]. 
For SLC26A4, the Invader assay evaluates 19 mutations including p.H723R, p.Y530H, p.T416P, 
p.Q514K, c.919-2A>G, and c.1001+1G>A, which are the most common mutations in the Asian, 
European, and American populations [14, 15, 17, 27-29]. In our case, the Invader assay detected 
only a p.T410M homozygous mutation of SLC26A4 among the 47 mutations in the assay, but 
additional mutations may have been present because we did not perform other tests, including direct 
sequencing of SLC26A4. Other mutations or polymorphisms in SLC26A4 and mutations in genes 
such as FOXI1, which regulates SLC26A4 expression, may exacerbate the phenotype of p.T410M 
homozygotes [30]. Therefore, the causal relationship between p.T410M homozygous SLC26A4 and 
the type of inner ear malformation in our case remains uncertain. An in vitro study showed that the 





exchange function of Pendrin in the endolymphatic sac is essential for normal inner ear development 


































































severe malformation in the cochlea. Recent studies have failed to identify a relationship between 
sites of mutations in SLC26A4 and phenotypes in patients with hearing loss, but most of these 
studies focused on clinical findings such as progression and fluctuation of hearing thresholds, goiter, 
and unilateral or bilateral EVA, rather than on cochlear malformations [18, 25, 32]. Thus, further 
studies are needed to evaluate the relationship between the severity of cochlear malformations and 
types of SLC26A4 mutations.  
 The presence or absence of an entire modiolus, which consists of a bony modiolus and soft 
tissue including neural elements, is clinically important when considering cochlear implantation. As 
pointed out previously, a CSF gusher is associated with inner ear malformations lacking an entire 
cochlear modiolus due to communication between the IAC and the malformed cochlea [4, 23, 33]. In 
our patient, we encountered a CSF gusher during implantation on the left side, but not on the right 
side, as predicted by MRI findings indicating a lack of the entire modiolus and the fundus of the IAC 
only on the left side. Evaluation of the presence of a modiolus is also useful to select an appropriate 
type of electrode array for the implant. CT failed to detect a bony modiolus on both sides in the 
present case, but MRI identified soft tissue (probably neuronal elements) at the center of the right 
cochlea. Therefore, we used a modiolar hugging electrode array on the right side to stimulate the 
putative neuronal tissue at the core of the cochlea using the closely positioned electrodes. It should 


































































indicate a need for use of a modiolar hugging electrode array because the precise distribution of 
neuronal elements is uncertain in this type of malformed cochleae. However, when the entire 
modiolus is absent, as for the left cochlea in our patient, the standard straight electrode array is 
recommended because neuronal tissue may be distributed near the inner wall of the cystic cochlea, 
as we previously showed in patients with a common cavity deformity [34]. 
 The patient underwent sequential cochlear implantation on the right side at 1 year old and 
on the left side at 6 years old. His implant-aided word discrimination score was excellent and 
reached 90% at 14 months after the first implantation, and his language development had caught up 
with that of children with normal hearing before the second implantation. Differences in severity of 
cochlear malformations may be associated with differences in cochlear implant outcomes. However, 
the short follow-up period after the second implantation and the 5-year gap between implantations 
made it difficult to evaluate the negative impacts of the more severe left cochlear malformation on 
implant-aided auditory performance. 
 
4. Conclusions 
 We have described the case of a congenitally deaf patient with a rare p.T410M 
homozygous mutation of the SLC26A4 gene. This patient had an unusual inner ear malformation that 


































































seen in IP-II, which is associated with SLC26A4 mutations, but the cystic cochleae without a bony 
modiolus were similar to features seen in IP-I. The causal relationship between a p.T410M 
homozygous mutation of SLC26A4 and this type of inner ear malformation remains unclear. 
However, these results suggest that homozygous mutations in SLC26A4 are always associated with 
EVA, but that the severity of cochlear malformations may vary widely depending on the type of 
SLC26A4 mutation. 
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9. Figure legends 
Fig.1. Axial CT images showing the right and left malformed inner ears in the present case who had 
a p.T410M homozygous mutation in the SLC26A4 gene (A-D), IP-I (E and F), and IP-II found in a 
patient who had a p.H723R homozygous mutation in the SLC26A4 gene (G and H). The upper 
column shows malformed cochleae in each inner malformation (arrow heads). An interscalar septum 
is observed in IP-II (G, black arrow), while the others show a cystic cochlea without a bony 
modiolus (A, C, and E). The present case has a minimally dilated vestibules (B and D, *), which are 
similar to that seen in IP-II (H, *), but differ from the large cystic vestibule in IP-I (F, black arrow). 
Both SLC26A4 mutations are associated with EVA (B, D, and H, white arrows). Scare bars: 5 mm. 
 
Fig.2. Axial T2-weighted MRI shows that soft tissue with low intensity is present at the center of the 
cochlea on the right side in the present case who had a p.T410M homozygous mutation in SLC26A4 
(A, arrow). On the other hand, the left side showed a complete empty cochlea without an entire 
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Table 1: Measurements of each part of malformed inner ears 
 Length of the 
basal portion of 
a cochlea (mm) 
Height of a 
cochlea (mm) 
Width of a 
vestibule (mm) 
Width of EVA 
at the midpoint 
of a vestibular 
aqueduct (mm) 
p.T410M Rt 8.81 4.93 4.03 3.73 
p.T410M Lt 9.10 5.51 4.18 4.33 
IP-I* 8.45 ± 0.68 5.04 ± 0.46 5.74 ± 0.68 N.E. 
IP-II* 8.10 ± 0.46 4.87 ± 0.19 4.26 ± 0.38 3.68 ± 0.36 
Normal* 8.59 ± 0.41 5.31 ± 0.41 3.40 ± 0.28 N.E. 
p.T410M Rt and Lt indicate the right and left inner ears of the present case, 
respectively. 
* Sennaroglu and Sacci 2004 [23]  
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